Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4202)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 9, 2022 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Critical Care Medicine
ISSN
2220-3141
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Selvaraj V, Lal A, Finn A, Tanzer JR, Baig M, Jindal A, Dapaah-Afriyie K, Bayliss G. Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease. World J Crit Care Med 2022; 11(1): 48-57 [PMID: 35433306 DOI: 10.5492/wjccm.v11.i1.48] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3141/full/v11/i1/48.htm |
| Number | Citing Articles |
| 1 |
Effat Davoudi-Monfared, Arezoo Ahmadi, Elahe Karimpour-Razkenari, Bita Shahrami, Farhad Najmeddin, Mojtaba Mojtahedzadeh. Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review. American Journal of Therapeutics 2022; 29(5): e520 doi: 10.1097/MJT.0000000000001543
|
| 2 |
Sonal Singh. Medication safety in chronic kidney disease. Current Opinion in Nephrology & Hypertension 2023; 32(5): 434 doi: 10.1097/MNH.0000000000000907
|